feed,title,long_url,short_url
Benzinga,AbbVie Shares Drop As Review For Upadacitinib US Application In Psoriatic Arthritis Pushed Back For Three Months,https://benzinga.com/general/biotech/21/03/20213091/abbvie-shares-drop-as-review-for-upadacitinib-us-application-in-psoriatic-arthritis-pushed-back-f,https://j.mp/3tmwg2u
